Whale's Bold ETH Move, Eli Lilly Drug Breakthrough, Europe Market Recovers

1. A whale investor, nemorino.eth, purchased 7,908.3 ETH worth $16.71 million in a leveraged move after liquidating at a loss days prior.
2. Eli Lilly's Phase 2 study of VERVE-102 revealed a single dose significantly reduces PCSK9 by up to 88% and LDL-C by up to 62%, potentially offering a one-time treatment for hypercholesterolemia.
3. The Euro Stoxx 50 index rose by 2%, completely erasing losses incurred since the start of the Iran war, signaling a recovery in European markets.